Association of estrogen receptor α gene polymorphisms with neurofibrillary tangles

Dementia and Geriatric Cognitive Disorders

Volumn 18, Issue 2, 2004, Pages 145-150

  Kazama, Hirohito ^a,c   Ruberu, Nyoka N ^a   Murayama, Shigeo ^a   Saito, Yuko ^a   Nakahara, Ken Ichi ^a   Kanemaru, Kazutomi ^a   Nagura, Hiroshi ^a   Arai, Tomio ^a   Sawabe, Motoji ^a   Yamanouchi, Hiroshi ^a   Orimo, Hajime ^b   Hosoi, Takayuki ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c Itabashi Chuo Medical Center   (Japan)

Author keywords

Alzheimer's disease; Estrogen receptor ; Neurofibrillary tangles; Polymorphism

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CADAVER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ESTROGEN RECEPTOR ALPHA GENE; FEMALE; GENE; GENE CONTROL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TECHNIQUE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; DISEASE PROGRESSION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; POLYMORPHISM, GENETIC; SENILE PLAQUES; TOKYO;

EID: 4344616023     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079194     Document Type: Article

References (20)

1. Combarros O, Alvarez-Arcaya A, Sanchez-Guerra M, Infante J, Berciano J: Candidate gene association studies in sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:41-54.
2. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC: Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer's disease in older women: The Cache County Study. JAMA 2002;288:2123-2129.
3. McEwen BS, Alves SE: Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
4. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H: Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996;11:306-311.
5. Isoe K, Ji Y, Urakami K, Adachi Y, Nakashima K: Genetic association of estrogen receptor gene polymorphisms with Alzheimer's disease. Alzheimers Res 1997;3:195-197.
6. Brandi ML, Becherini L, Gennari L, Racchi M, Bianchetti A, Nacmias B, Sorbi S, Mecocci P, Senin U, Govoni S: Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun 1999;265:335-338.
7. Ji Y, Urakami K, Wada-Isoe K, Adachi Y, Nakashima K: Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia, and alcohol-associated dementia. Dement Geriatr Cogn Disord 2000;11:119-122.
8. Mattila KM, Axelman K, Rinne JO, Blomberg M, Lehtimaki T, Laippala P, Roytta M, Viitanen M, Wahlund L, Winblad B, Lannfelt L: Interaction between estrogen receptor 1 and the ε4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett 2000;282:45-48.
9. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T, Arai H, Yasuda M, Tanaka C, Emson PC, Nakamura S, Kawakami H: Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer's disease. Arch Neurol 2000;57:236-240.
10. Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A, St-Clair D, Lendon C: Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001;306:193-197.
11. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
12. Saito Y, Murayama S: Expression of tau immunoreactivity in the spinal motor neurons of Alzheimer's disease. Neurology 2000;55:1727-1729.
13. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res1976;3:2303-2308.
14. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
15. Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K: A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993;163:166-168.
16. Price JL, Morris JC: Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease. Ann Neurol 1999;45:358-368.
17. Nakahara K, Matsushita S, Matsuoka H, Inamatsu T, Nishinaga M, Yonawa M, Aono T, Arai T, Ezaki Y, Orimo H: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight. Circulation 2000;101:148-151.
18. Kazama H, Hosoi T, Nakahara K, Murayama S, Saito Y, Kanemaru K, Nagura H, Arai T, Sawabe M, Toba K, Yamanouchi H, Orimo H: Association between a promoter polymorphism of the paraoxonase PON1 gene and pathologically verified idiopathic Parkinson's disease. Geriatr Gerontol Int 2002;2:91-96.
19. Gold G, Bouras C, Kovari E, Canuto A, Glaria BG, Malky A, Hof PR, Michel JP, Giannakopoulos P: Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol (Berl) 2000;99:579-582.
20. Morris JC: Is Alzheimer's disease inevitable with age? Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease. J Clin Invest 1999;104:1171-1173.